363 related articles for article (PubMed ID: 17582944)
21. Prognostic value of computer-assisted morphological and morphometrical analysis for detecting the recurrence tendency of basal cell carcinoma.
Cheretis C; Angelidou E; Dietrich F; Politi E; Kiaris H; Koutselini H
Med Sci Monit; 2008 May; 14(5):MT13-19. PubMed ID: 18443558
[TBL] [Abstract][Full Text] [Related]
22. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
23. Difficult to diagnose skin cancer--the 'aggressive' BCC.
Tomas S
Aust Fam Physician; 2009 Jul; 38(7):492-7. PubMed ID: 19575067
[TBL] [Abstract][Full Text] [Related]
24. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
25. 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome.
Häfner HM; Breuninger H; Moehrle M; Trilling B; Krimmel M
Int J Oral Maxillofac Surg; 2011 Sep; 40(9):943-8. PubMed ID: 21600736
[TBL] [Abstract][Full Text] [Related]
26. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
27. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
28. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
29. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
30. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
31. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
32. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
33. Basal cell carcinoma with metastasis. Review of literature.
Safai B; Good RA
Arch Pathol Lab Med; 1977 Jun; 101(6):327-31. PubMed ID: 67830
[TBL] [Abstract][Full Text] [Related]
34. Linear basal cell carcinoma: a distinct clinical entity in the periocular region.
Mavrikakis I; Malhotra R; Barlow R; Huilgol SC; Selva D
Ophthalmology; 2006 Feb; 113(2):338-42. PubMed ID: 16406534
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
36. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
37. [Depth of invasion of basaliomas].
Breuninger H; Flad P; Rassner G
Z Hautkr; 1989 Mar; 64(3):191-6. PubMed ID: 2718551
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
39. Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma.
Mosterd K; Thissen MR; van Marion AM; Nelemans PJ; Lohman BG; Steijlen PM; Kelleners-Smeets NW
J Am Acad Dermatol; 2011 Feb; 64(2):323-7. PubMed ID: 21238826
[TBL] [Abstract][Full Text] [Related]
40. Keloidal basal cell carcinoma: not a distinctive clinicopathological entity.
Jones M; Bresch M; Alvarez D; Böer A
Br J Dermatol; 2009 Jan; 160(1):127-31. PubMed ID: 18795924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
